Tune in as PwC specialists discuss the 2024 outlook for healthcare and how the sector can grow and innovate amid economic challenges and uncertainty.

Key Topics include:

• Major forces impacting the sector: economic pressure, rising costs, labor shortage, and expensive drugs
• Ways to overcome compression and deliver value: industry-wide transformation, tech enabled business model reinvention, transactions and deals to drive transformation, and building trust

Speakers:
Laura Robinette, Health Industries Trust Solutions Leader, PwC, US
Thom Bales, Health Services Leader, PwC, US
Jenny Colapietro, Health Industries Vice Chair, PwC, US

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune in to hear PwC specialists discuss strategies to reinvent the pharma business model and drive growth in the pharmaceutical industry.

Key topics include:

• The headwinds for pharma are real and sustained
• Rethinking the innovation strategy
• Accelerate using AI and analytics
• Lower costs
• M&A as a catalyst for transformation
• Protecting the enterprise

Speakers:

Jenny Colapietro, Health Industries Vice Chair, PwC
Glenn Hunzinger, Pharmaceutical and Life Sciences Leader, PwC
Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader, PwC

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune in to hear PwC Deals leaders discuss preparing for deals in 2024, exploring the current state of the deals market and sharing valuable insights from their newly released 2024 deals outlook. Key topics include:

• Fundamental changes and strategy trends for 2024 and how it’s shaping the health services and pharma landscapes
• The role of the regulators and their impact on deals
• Business model reinvention and the use of new technology to acquire better data and how it’s shaping the deals environment for 2024
• What’s on the horizon: Key success factors for good deal making in 2024

Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC
Igor Belokrinitsky, Strategy& Principal, PwC

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.